Arsida Bajrami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arsida Bajrami has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Songul Senadim
Department of Neurology, Istanbul Aydin University Faculty of Medicine, Istanbul, Türkiye
7 shared publications - Sena Aksoy
Department of Neurology, Istanbul Aydin University Faculty of Medicine, Istanbul, Türkiye
5 shared publications - Serdar Geyik
Department of Radiology, Istanbul Aydin University Faculty of Medicine, Istanbul, Türkiye
4 shared publications Filiz Azman
Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Department of Neurology, Istanbul, Turkey
2 shared publicationsSerdar Geyik
Department of Neurology, Istanbul Aydin University, Istanbul, Turkey
2 shared publications- Serdar Geyik
Istanbul Aydın University Florya Medicalpark Hospital Stroke Center, Neuroradiology, Istanbul, Turkey
2 shared publications
Latest Publications
- Open Access
- 14 May 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (5) , 526
Mechanical Thrombectomy in Patients with Malignancy: Comparable Procedural Success but Less Favorable Long-Term Outcomes
Background and Aims: Patients with malignancy are frequently excluded from randomized thrombectomy trials, and evidence regarding the safety and efficacy of mechanical thrombectomy (MT) in this population remains incompletely defined. We aimed to compare procedural success, functional outcomes, and mortality between acute ischemic stroke (AIS) patients with and without malignancy undergoing MT. Methods: We retrospectively analyzed 110 patients treated with MT. Patients were stratified into two groups: those with malignancy (n = 48) and those without malignancy (n = 62). Baseline demographics, vascular risk factors, procedural metrics, angiographic outcomes, and clinical outcomes including functional independence (modified Rankin Scale [mRS] 0–2), 90-day mortality and intracranial hemorrhage were compared. Results: Baseline demographics and admission stroke severity were similar between groups. Smoking was significantly more frequent in the malignancy group (25% vs. 11.3%, p < 0.001). Successful reperfusion (TICI 2b-3) was achieved in 95.8% of malignancy patients and 98.4% of controls (p = 0.51). Functional independence at 90 days was lower in the malignancy group (42.6% vs. 61.3%, p = 0.04), whereas 90-day mortality was significantly higher (44.7% vs. 19.4%, p = 0.004); this increase in mortality remained significant after multivariate analysis. There were no significant differences in rates of intracranial hemorrhage between groups (p = 0.53). Conclusions: Mechanical thrombectomy is technically effective and safe in patients with malignancy; however, long-term functional recovery and survival are significantly worse, likely reflecting the effect of cancer itself rather than procedural factors. Careful patient selection and multidisciplinary decision-making are essential in this population.
- 14 May 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (5) , 526
Open AccessMechanical Thrombectomy in Patients with Malignancy: Comparable Procedural Success but Less Favorable Long-Term Outcomes
Background and Aims: Patients with malignancy are frequently excluded from randomized thrombectomy trials, and evidence regarding the safety and efficacy of mechanical thrombectomy (MT) in this population remains incompletely defined. We aimed to compare procedural success, functional outcomes, and mortality between acute ischemic stroke (AIS) patients with and without malignancy undergoing MT. Methods: We retrospectively analyzed 110 patients treated with MT. Patients were stratified into two groups: those with malignancy (n = 48) and those without malignancy (n = 62). Baseline demographics, vascular risk factors, procedural metrics, angiographic outcomes, and clinical outcomes including functional independence (modified Rankin Scale [mRS] 0–2), 90-day mortality and intracranial hemorrhage were compared. Results: Baseline demographics and admission stroke severity were similar between groups. Smoking was significantly more frequent in the malignancy group (25% vs. 11.3%, p < 0.001). Successful reperfusion (TICI 2b-3) was achieved in 95.8% of malignancy patients and 98.4% of controls (p = 0.51). Functional independence at 90 days was lower in the malignancy group (42.6% vs. 61.3%, p = 0.04), whereas 90-day mortality was significantly higher (44.7% vs. 19.4%, p = 0.004); this increase in mortality remained significant after multivariate analysis. There were no significant differences in rates of intracranial hemorrhage between groups (p = 0.53). Conclusions: Mechanical thrombectomy is technically effective and safe in patients with malignancy; however, long-term functional recovery and survival are significantly worse, likely reflecting the effect of cancer itself rather than procedural factors. Careful patient selection and multidisciplinary decision-making are essential in this population.
- Open Access
- 25 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1288
Angiographic Success Does Not Fully Reflect Tissue-Level Reperfusion: New Diffusion-Weighted Imaging Lesions After True Complete (TICI 3) Recanalization
Background and Purpose: Complete angiographic reperfusion (TICI 3) is considered the optimal procedural endpoint of mechanical thrombectomy (MT) in acute ischemic stroke. However, new diffusion-weighted imaging (DWI) lesions are frequently observed despite apparent angiographic success. We aimed to investigate the incidence, morphological patterns, and clinical relevance of these lesions in a strictly defined TICI 3 cohort. Methods: In this retrospective single-center study, 89 patients with anterior circulation large-vessel occlusion (LVO) who achieved true TICI 3 were analyzed. Baseline and follow-up Magnetic Resonance Imaging (MRI) within 48 h were systematically compared using paired diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps to identify new lesions. Lesions were classified according to morphology and distribution. Stroke etiology was assessed using TOAST criteria. Functional outcomes were evaluated using the 90-day modified Rankin Scale (mRS) with the Rankin Focused Assessment. Results: New DWI lesions were detected in 28 of 89 patients (31.5%). The predominant pattern was millimetric cortical foci (85.7%), most frequently ipsilateral to the recanalized vessel (78.6%), with fewer contralateral (14.3%) and bilateral (7.1%) lesions. Territorial infarcts and isolated basal ganglia infarcts were each identified in 14.3% of patients, with some overlap between categories. No significant differences were observed between patients with and without new lesions regarding baseline characteristics or procedural metrics (all p > 0.05). Importantly, the presence of new DWI lesions was not associated with 90-day functional outcome (p = 0.930) or survival (p = 0.613). Conclusions: New DWI lesions are common even after complete angiographic reperfusion, highlighting a persistent dissociation between macrovascular success and tissue-level integrity. Although predominantly small and clinically silent in the short term, these findings underscore the limitations of angiographic endpoints alone and support the need for strategies targeting microvascular protection and prevention of distal embolization.
- 25 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1288
Open AccessAngiographic Success Does Not Fully Reflect Tissue-Level Reperfusion: New Diffusion-Weighted Imaging Lesions After True Complete (TICI 3) Recanalization
Background and Purpose: Complete angiographic reperfusion (TICI 3) is considered the optimal procedural endpoint of mechanical thrombectomy (MT) in acute ischemic stroke. However, new diffusion-weighted imaging (DWI) lesions are frequently observed despite apparent angiographic success. We aimed to investigate the incidence, morphological patterns, and clinical relevance of these lesions in a strictly defined TICI 3 cohort. Methods: In this retrospective single-center study, 89 patients with anterior circulation large-vessel occlusion (LVO) who achieved true TICI 3 were analyzed. Baseline and follow-up Magnetic Resonance Imaging (MRI) within 48 h were systematically compared using paired diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps to identify new lesions. Lesions were classified according to morphology and distribution. Stroke etiology was assessed using TOAST criteria. Functional outcomes were evaluated using the 90-day modified Rankin Scale (mRS) with the Rankin Focused Assessment. Results: New DWI lesions were detected in 28 of 89 patients (31.5%). The predominant pattern was millimetric cortical foci (85.7%), most frequently ipsilateral to the recanalized vessel (78.6%), with fewer contralateral (14.3%) and bilateral (7.1%) lesions. Territorial infarcts and isolated basal ganglia infarcts were each identified in 14.3% of patients, with some overlap between categories. No significant differences were observed between patients with and without new lesions regarding baseline characteristics or procedural metrics (all p > 0.05). Importantly, the presence of new DWI lesions was not associated with 90-day functional outcome (p = 0.930) or survival (p = 0.613). Conclusions: New DWI lesions are common even after complete angiographic reperfusion, highlighting a persistent dissociation between macrovascular success and tissue-level integrity. Although predominantly small and clinically silent in the short term, these findings underscore the limitations of angiographic endpoints alone and support the need for strategies targeting microvascular protection and prevention of distal embolization.
- Open Access
- 20 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 276
Correction to: Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report
- 20 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 276
Open AccessCorrection to: Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report
- 15 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 164
Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report
- 15 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 164
Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report
- 7 December 2024
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (4) , 511-513
A comatose vertebrobasilar occlusion patient recovering with bilateral hearing loss following full recanalization with mechanical thrombectomy
Acute occlusion of vertebrobasilar artery mostly presents with severe neurologic impairment. Bilateral sensorineural hearing loss (SNHL) as the first clinical symptom on onset is a rare phenomenon. Clinical benefit of mechanical thrombectomy (MT) in terms of hearing loss in these cases is poorly understood. We describe a case of a patient with vertebrobasilar occlusion who presented with only sudden bilateral SNHL and recovered poorly in terms of hearing loss after full recanalization with MT. We describe a 52-year-old right-handed male patient with an unremarkable medical history. On admission, he was hypertensive to 200/102 mm Hg; neurological examination was significant for mild right facial palsy and bilateral SNHL, later confirmed by an audiogram. diffusion-weighted imaging (DWI) showed infarction of bilateral anterior cerebellum, cerebellar peduncles, and pons with negative flair. Computed tomography angiography showed occlusion in the level of the vertebrobasilar junction. Patients’ neurological status deteriorated within hours into a comatose status with anarthria and quadriplegia. He was treated with MT and stenting and full recanalization was achieved. All neurological examination findings have completely resolved, except for the bilateral SNHL. Acute onset of sudden bilateral deafness in isolation or accompanied by vestibular, cerebellar, and/or brainstem signs may indicate large vessel occlusion. Although rapid recanalization with MT helps improve the symptoms, the specific impact over SNHL varies between patients.
- 7 December 2024
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (4) , 511-513
A comatose vertebrobasilar occlusion patient recovering with bilateral hearing loss following full recanalization with mechanical thrombectomy
Acute occlusion of vertebrobasilar artery mostly presents with severe neurologic impairment. Bilateral sensorineural hearing loss (SNHL) as the first clinical symptom on onset is a rare phenomenon. Clinical benefit of mechanical thrombectomy (MT) in terms of hearing loss in these cases is poorly understood. We describe a case of a patient with vertebrobasilar occlusion who presented with only sudden bilateral SNHL and recovered poorly in terms of hearing loss after full recanalization with MT. We describe a 52-year-old right-handed male patient with an unremarkable medical history. On admission, he was hypertensive to 200/102 mm Hg; neurological examination was significant for mild right facial palsy and bilateral SNHL, later confirmed by an audiogram. diffusion-weighted imaging (DWI) showed infarction of bilateral anterior cerebellum, cerebellar peduncles, and pons with negative flair. Computed tomography angiography showed occlusion in the level of the vertebrobasilar junction. Patients’ neurological status deteriorated within hours into a comatose status with anarthria and quadriplegia. He was treated with MT and stenting and full recanalization was achieved. All neurological examination findings have completely resolved, except for the bilateral SNHL. Acute onset of sudden bilateral deafness in isolation or accompanied by vestibular, cerebellar, and/or brainstem signs may indicate large vessel occlusion. Although rapid recanalization with MT helps improve the symptoms, the specific impact over SNHL varies between patients.
- Open Access
- 1 January 2024
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 58 (4) , 422-429
Outcome of Mechanical Thrombectomy in Patients Older Than 85 Years: A Single Center Experience
The Medical Bulletin of Sisli Etfal Hospital
- 1 January 2024
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 58 (4) , 422-429
Open AccessOutcome of Mechanical Thrombectomy in Patients Older Than 85 Years: A Single Center Experience
The Medical Bulletin of Sisli Etfal Hospital
- Open Access
- 2 December 2023
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (12) , 1220-1227
Primary results from the CLEAR study of a novel stent retriever with drop zone technology
Background Challenges to revascularization of large vessel occlusions (LVOs) persist. Current stent retrievers have limited effectiveness for removing organized thrombi. The NeVa device is a novel stent retriever designed to capture organized thrombi within the scaffold during retrieval. Objective To evaluate the safety and effectiveness of revascularization of acute LVOs with the NeVa device. Methods Prospective, international, multicenter, single-arm, Investigational Device Exemption study to evaluate the performance of the NeVa device in recanalizing LVOs including internal carotid artery, M1/M2 middle cerebral artery, and vertebrobasilar arteries, within 8 hours of onset. Primary endpoint was rate of expanded Treatment in Cerebral Ischemia (eTICI) score 2b–3 within 3 NeVa passes, tested for non-inferiority against a performance goal of 72% with a −10% margin. Additional endpoints included first pass success and 90-day modified Rankin Scale (mRS) score 0–2. Primary composite safety endpoint was 90-day mortality and/or 24-hour symptomatic intracranial hemorrhage (sICH). Results From April 2021 to April 2022, 139 subjects were enrolled at 25 centers. Median National Institutes of Health Stroke Scale (NIHSS) score was 16 (IQR 12–20). In the primary analysis population (n=107), eTICI 2b–3 within 3 NeVa passes occurred in 90.7% (97/107; non-inferiority PConclusions The NeVa device is highly effective and safe for revascularization of LVO strokes and demonstrates superior first pass success compared with a predicate performance goal. Trial registration number NCT04514562.
- 2 December 2023
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (12) , 1220-1227
Open AccessPrimary results from the CLEAR study of a novel stent retriever with drop zone technology
Background Challenges to revascularization of large vessel occlusions (LVOs) persist. Current stent retrievers have limited effectiveness for removing organized thrombi. The NeVa device is a novel stent retriever designed to capture organized thrombi within the scaffold during retrieval. Objective To evaluate the safety and effectiveness of revascularization of acute LVOs with the NeVa device. Methods Prospective, international, multicenter, single-arm, Investigational Device Exemption study to evaluate the performance of the NeVa device in recanalizing LVOs including internal carotid artery, M1/M2 middle cerebral artery, and vertebrobasilar arteries, within 8 hours of onset. Primary endpoint was rate of expanded Treatment in Cerebral Ischemia (eTICI) score 2b–3 within 3 NeVa passes, tested for non-inferiority against a performance goal of 72% with a −10% margin. Additional endpoints included first pass success and 90-day modified Rankin Scale (mRS) score 0–2. Primary composite safety endpoint was 90-day mortality and/or 24-hour symptomatic intracranial hemorrhage (sICH). Results From April 2021 to April 2022, 139 subjects were enrolled at 25 centers. Median National Institutes of Health Stroke Scale (NIHSS) score was 16 (IQR 12–20). In the primary analysis population (n=107), eTICI 2b–3 within 3 NeVa passes occurred in 90.7% (97/107; non-inferiority PConclusions The NeVa device is highly effective and safe for revascularization of LVO strokes and demonstrates superior first pass success compared with a predicate performance goal. Trial registration number NCT04514562.
- 11 November 2016
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 30 (1) , 23-27
MRI findings and cognitive functions in a small cohort of myotonic dystrophy type 1: Retrospective analyses
Myotonic dystrophy type 1 (DM1) is a progressive multisystemic disease with common cognitive deficits and potential brain involvement in addition to the cardinal muscular and systemic symptoms. Impaired mental function associated with nonspecific pathological findings such as white-matter hyperintense lesions (WMHLs), ventricular enlargement and brain atrophy on brain MRI have been previously reported in DM1 patients. While some studies showed correlation of brain morphological changes with neuropsychological and clinical parameters including CTG repeat sizes and disease severity scales in DM1, others failed. The goal of this study was to retrospectively investigate cranial MR abnormalities, predominantly WMHLs, and their effects on clinical and cognitive deficits in a small, phenotypically or genotypically well-characterized cohort of DM1 patients.
- 11 November 2016
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 30 (1) , 23-27
MRI findings and cognitive functions in a small cohort of myotonic dystrophy type 1: Retrospective analyses
Myotonic dystrophy type 1 (DM1) is a progressive multisystemic disease with common cognitive deficits and potential brain involvement in addition to the cardinal muscular and systemic symptoms. Impaired mental function associated with nonspecific pathological findings such as white-matter hyperintense lesions (WMHLs), ventricular enlargement and brain atrophy on brain MRI have been previously reported in DM1 patients. While some studies showed correlation of brain morphological changes with neuropsychological and clinical parameters including CTG repeat sizes and disease severity scales in DM1, others failed. The goal of this study was to retrospectively investigate cranial MR abnormalities, predominantly WMHLs, and their effects on clinical and cognitive deficits in a small, phenotypically or genotypically well-characterized cohort of DM1 patients.
- 1 May 2015
- Vol. 65 (5) , 561-4
Baloon angioplasty for venous sinus stenosis in a idiopathic intracranial hypertension case.
The Idiopathic Intracranial Hypertension (IIH) is a well characterised condition with intractable headaches, visual obscurations, and papilloedema as dominant features, mainly affecting obese women. With the advent of magnetic resonance (MR) venography and increased use of cerebral angiography, there has been recent emphasis on the significant number of patients with IIH found to have associated non-thrombotic dural venous sinus stenosis. This has led to a renewed interest in endovascular stenting and angioplasty as a treatment for IIH in patients non-responsive to medical treatment. We present a patient without known risk factors for IIH and non-responsive to treatment. The 19-year-old woman presented with headache and diplopia. She was diagnosed with IIH since she was five years of age and had been non-responsive to lumbar cerebrospinal fluid (CSF) drainage and acetazolamide treatment. MR venography revealed thin calibration of transverse sinus. Digital subtraction angiography (DSA) venous phase also revealed 50% stenosis of transverse sinus, 50% stenosis of left proximal sigmoid sinus and 90% stenosis of its distal part leading to obstruction of left transverse sinus outflow and forced directed drainage of left hemisphere to the anterior region.
- 1 May 2015
- Vol. 65 (5) , 561-4
Baloon angioplasty for venous sinus stenosis in a idiopathic intracranial hypertension case.
The Idiopathic Intracranial Hypertension (IIH) is a well characterised condition with intractable headaches, visual obscurations, and papilloedema as dominant features, mainly affecting obese women. With the advent of magnetic resonance (MR) venography and increased use of cerebral angiography, there has been recent emphasis on the significant number of patients with IIH found to have associated non-thrombotic dural venous sinus stenosis. This has led to a renewed interest in endovascular stenting and angioplasty as a treatment for IIH in patients non-responsive to medical treatment. We present a patient without known risk factors for IIH and non-responsive to treatment. The 19-year-old woman presented with headache and diplopia. She was diagnosed with IIH since she was five years of age and had been non-responsive to lumbar cerebrospinal fluid (CSF) drainage and acetazolamide treatment. MR venography revealed thin calibration of transverse sinus. Digital subtraction angiography (DSA) venous phase also revealed 50% stenosis of transverse sinus, 50% stenosis of left proximal sigmoid sinus and 90% stenosis of its distal part leading to obstruction of left transverse sinus outflow and forced directed drainage of left hemisphere to the anterior region.